Dark

Check out our Dark Pool Levels

AIKI
AIkido Pharma Inc. Common Stock
stock NASDAQ

Inactive

Dec 21, 2022

3.56USD+0.282%(+0.01)31,931

Pre-market

0.00USD-100.000%(-3.55)0

After-hours

0.00USD0.000%(0.00)0

OverviewHistoricalExchangesShortsNews

Jan 24, 2022

01:32PM EST AIkido Pharma Announces $3M Buyback Benzinga

01:30PM EST AIkido Pharma Announces Share Repurchase Program PR Newswire

Jan 5, 2022

10:02AM EST AIkido Pharma Announces Dr. Rachel Yehuda's Appearance on CBS News PR Newswire

Dec 14, 2021

10:02AM EST AIkido Pharma Offers Status Update On Its Expansion Of Key Patent Applications Into Several Major Ex-US Territories Worldwide Benzinga

10:01AM EST AIkido Pharma Reports Filing for Expanded Worldwide Patent Coverage on Key PR Newswire

Dec 6, 2021

10:01AM EST AIkido Pharma Announces Strategic Interest in ASP Isotopes Inc. PR Newswire

Nov 12, 2021

09:51AM EST /C O R R E C T I O N -- AIkido Pharma Inc./ PR Newswire

Nov 11, 2021

10:03AM EST AIkido Pharma Reports Cash, Cash Investments $104M+ For Q3, Provides Updates On Other Highlights From Last Qtr. Benzinga

10:01AM EST AIkido Pharma Announces Third Quarter Highlights and Corporate Update PR Newswire

Oct 22, 2021

02:36PM EDT Trump-Linked SPAC Has Traders Also Focused On These 6 Stocks Benzinga

Oct 11, 2021

10:51AM EDT Benzinga's Top Ratings Upgrades, Downgrades For October 11, 2021 Benzinga

06:15AM EDT HC Wainwright & Co. Initiates Coverage On AIkido Pharma with Buy Rating, Announces Price Target of $2 Benzinga

Oct 6, 2021

09:27AM EDT Alkido Pharma Trading 30% Below Cash Value Despite Positive Indications Benzinga

Sep 28, 2021

10:46AM EDT AIkido Pharma Secures Equity Interest In Tevva Motors RTTNews

10:45AM EDT AIkido Pharma Secures Interest in Electric Truck Maker, Tevva Motors Ltd PR Newswire

Sep 20, 2021

09:03AM EDT AIkido Pharma Secures Interest In Growing Tele-health Company, Kerna Health; No Financial Terms Disclosed Benzinga

09:03AM EDT AIkido Pharma Secures Interest in Growing Tele-health Company PR Newswire

Sep 14, 2021

09:25AM EDT AIkido Pharma Releases Shareholder Update (Full Statement In Body) Benzinga

09:23AM EDT AIkido Pharma Releases Shareholder Update; Near Term Catalysts Approaching PR Newswire

Aug 9, 2021

10:23AM EDT A Look Into Healthcare Sector Value Stocks Benzinga

Aug 6, 2021

10:02AM EDT AIkido Updates On Use Of Machine Learning In Drug Development Program RTTNews

10:02AM EDT AIkido Pharma Offers Update On Use Of Machine Learning In Drug Development Program: 'The goal for the project is the identification and optimization of anti-viral compounds that inhibit viral replication by targeting a protein complex that degrades RNA... Benzinga

10:01AM EDT AIkido Provides Update on Use of Machine Learning in Drug Development Program PR Newswire

Jul 27, 2021

11:13AM EDT AIkido Pharma Announces Notice Of Allowance For U.S. Patent For Technology For Use Of 'ovel and proprietary central nervous system (CNS) homing peptides' Benzinga

Jul 26, 2021

10:24AM EDT 5 Value Stocks In The Healthcare Sector Benzinga

Jul 16, 2021

10:01AM EDT AIkido Pharma Issues Update on Antiviral Platform with the University of PR Newswire

10:01AM EDT AIkido Pharma Issues Update On Antiviral Platform With The University Of Maryland Benzinga

Jul 13, 2021

10:03AM EDT AIkido Pharma To Attend Alzheimer's Association International Conference Benzinga

Jun 28, 2021

10:27AM EDT A Look Into Healthcare Sector Value Stocks Benzinga

Jun 23, 2021

10:03AM EDT AIkido Files Patent Application For Use Of Ketamine To Treat Alzheimer's Disease RTTNews

10:01AM EDT AIkido Pharma Files Patent Application for the Use of Ketamine to Treat PR Newswire

10:01AM EDT AIkido Pharma Files Patent Application For Use Of Ketamine To Treat Alzheimer's Disease Benzinga

Jun 21, 2021

10:18AM EDT 5 Value Stocks To Watch In The Healthcare Sector Benzinga

Jun 7, 2021

09:42AM EDT Overview Of Value Stocks In The Healthcare Sector Benzinga

Jun 4, 2021

09:18AM EDT AIkido Pharma Highlights Presentation Of Phase 1 Data At American Society Of Clinical Oncology Jun. 4 Benzinga

09:01AM EDT AIkido Pharma Announces Positive Phase 1 Data Presented at ASCO on 225Ac-J591 PR Newswire

May 24, 2021

09:50AM EDT 5 Value Stocks To Watch In The Healthcare Sector Benzinga

May 20, 2021

03:25PM EDT Alkido Pharma Says Has Pending Data Results On June 4th Benzinga

09:39AM EDT AIkido Pharma : Phase 1 Data To Be Presented At American Society Of Clinical Oncology Annual Meeting RTTNews

09:21AM EDT AIkido Pharma To Present Data From Phase 1 Study Of 225Ac-J591 At ASCO Meeting Jun. 4 Benzinga

09:17AM EDT AIkido Pharma Announces Phase 1 Data To Be Presented at the American Society of PR Newswire

May 12, 2021

09:08AM EDT AIkido Pharma To Present At Benzinga Global SmallCap Conference May 13, Investor Summit Group's Q2 Virtual Summit May 17-19 And LD Micro Invitational XI Investor Conference Jun. 8-10 Benzinga

09:02AM EDT Investor Summit Group's Conference, and the LD Micro Invitational Conference PR Newswire

May 11, 2021

09:06AM EDT AIkido Pharma Reports Cash Balance Of $102 Mln Or About $1.15 Per Share As Of March 31st RTTNews

09:04AM EDT AIkido Pharma Inc. Announces First Quarter 2021 Results and Provides Corporate PR Newswire

09:03AM EDT AIkido Pharma Says Had Cash And Equivalents $102M On Mar. 31 Benzinga

Apr 27, 2021

10:01AM EDT AIkido Pharma Announces Dr. Rachel Yehuda's Appearance at SXSW PR Newswire

Apr 26, 2021

09:07AM EDT AIkido Pharma Names Matthew Frieman Scientific Advisory Board RTTNews

09:02AM EDT AIkido Pharma Announces Inventor and Scientist Dr. Matthew Frieman Joins PR Newswire

Apr 22, 2021

09:13AM EDT AIkido Pharma Announces Withdrawal Of S-1 Registration Statement RTTNews

Apr 21, 2021

11:34AM EDT AIkido Pharma Withdraws Offering In SEC Filing Benzinga

Apr 16, 2021

10:02AM EDT AIkido Pharma Notes Advancement In Radiopharmaceutical Research; Co Highlights Study Announcing Early Results From PSMA 617-Lu177 Study Benzinga

10:01AM EDT AIkido Pharma Notes Advancement in Radiopharmaceutical Research PR Newswire

Apr 7, 2021

10:39AM EDT Aikido Secures Sublicense For Psilocybin Treatment of Neuro-Inflamed Tissue in Cancer Patients Benzinga

09:09AM EDT AIkido Secures Sublicense To Technology For Targeted Psilocybin Treatment Of Neuro-Inflamed Tissue In Cancer Patients RTTNews

09:02AM EDT AIkido Granted Sublicense to Technology for Targeted Psilocybin Treatment of PR Newswire

09:02AM EDT AIkido Pharma Reports Was Granted Sublicense To Technology For Targeted Psilocybin Treatment Of Neuro-Inflamed Tissue In Cancer Patients Benzinga

Apr 5, 2021

09:06AM EDT AIkido Pharma Says Sufficiently Capitalized To Support Current Efforts And To Pursue Additional Emerging Opportunities RTTNews

09:03AM EDT AIkido Pharma Provides Business Update Benzinga

Mar 29, 2021

09:03AM EDT AIkido Pharma Sponsors Psychedelic Compound Research to Treat PTSD Benzinga

Mar 24, 2021

12:42PM EDT AIkido Pharma Spokesperson Tells Benzinga When Asked About Non-Fungible Token Connection 'This is only a rumor and the company does not use any NFT platforms' Benzinga

Mar 12, 2021

10:02AM EST AIkido Pharma Announces Dr. Matt Frieman's Appearance on This Week in Virology PR Newswire

Mar 4, 2021

09:01AM EST AIkido Pharma Inc. Updates Announcement of Webcast Link for the H.C. Wainwright PR Newswire

Mar 1, 2021

09:49AM EST A Look Into Healthcare Sector Value Stocks Benzinga

09:02AM EST AIkido Pharma Inc. to Present at the H.C. Wainwright Global Life Sciences PR Newswire

Feb 25, 2021

02:59PM EST AIkido Pharma Shares Spike Higher Following 13D Filing From FiveT Showing Fund Liquidated Position Benzinga

02:58PM EST AIkido Pharma 13D Filing From FiveT Investment Mgmt. Shows 0% Stake In Co. Benzinga

09:57AM EST CVI Investments Reports In 13G Filing A 6.1% Stake In Alkido Pharma Benzinga

Feb 23, 2021

10:57AM EST AIkido Pharma Inc. Announces Exercise of Option to Purchase Additional Shares PR Newswire

Feb 22, 2021

09:02AM EST AIkido Pharma Provides Update On Antiviral Platform; Says New Compounds Being Tested Against Influenza With SARS-CoV-2 Testing In The Future Benzinga

09:01AM EST AIkido Pharma Provides Update on its Antiviral Platform, Including the Virus PR Newswire

Feb 19, 2021

11:17AM EST AIkido Pharma Announces Closing Of $75 Mln Bought Deal Offering Of Common Stock RTTNews

11:11AM EST AIkido Pharma Inc. Announces Closing of $75 Million Bought Deal Offering of PR Newswire

Feb 17, 2021

07:27AM EST The Daily Biotech Pulse: Novartis Funding For Gene Therapy Research, Priority Review For Amgen Cancer Drug, Pfizer-BioNTech Vaccine Supply Deal Benzinga

06:52AM EST Aikido Pharma Slumps On $75M Upsized Equity Offering Issued At 25% Discount Benzinga

05:41AM EST AIkido Pharma Increased Bought Deal Offering of Common Stock to 46.875M Shares Priced @$1.60/Share Benzinga

Feb 16, 2021

10:16PM EST AIkido Pharma Increases Bought Deal Offering Of Common Stock To $75 Mln RTTNews

10:15PM EST AIkido Pharma Inc. Increases Previously Announced Bought Deal Offering of PR Newswire

04:49PM EST AIkido Pharma Announces That H.C. Wainwright & Co Agreed To By 6.250M Share Of Its Common Stock At $1.60 Per Share Benzinga

04:47PM EST AIkido Pharma Inc. Announces $10 Million Bought Deal Offering Of Common Stock PR Newswire

08:39AM EST AIkido Pharma Enters Into LoI With Silo Pharma For Use Of Psilocybin And Peptide Therapy For Cancer Treatment RTTNews

08:37AM EST AIkido Pharma Enters Into Letter Of Intent With Silo Pharma For Use Of Psilocybin And Peptide Therapy For Cancer Treatment Benzinga

08:31AM EST AIkido Pharma Enters Into Letter Of Intent With Silo Pharma for Use of PR Newswire

Feb 12, 2021

01:34PM EST CORRECTION: Aphria Ticker Is 'APHA' Benzinga

Feb 3, 2021

09:03AM EST AIkido Pharma Appoints Dr. Scott T. Tagawa, M.D. to Scientific Advisory Board PR Newswire

Feb 2, 2021

09:02AM EST AIkido Pharma Adds Inventor Dr. Neil H. Bander, M.D. to Scientific Advisory PR Newswire

Feb 1, 2021

08:03AM EST Aikido Pharma Secures Early Interest in Next Generation Radiotherapy PR Newswire

Jan 25, 2021

09:49AM EST 5 Value Stocks In The Healthcare Sector Benzinga

Jan 22, 2021

01:45PM EST AIkido Pharma Regains Compliance With NASDAQ Listing Requirements RTTNews

01:31PM EST AIkido Pharma Inc. Regains Compliance With NASDAQ Listing Requirements Benzinga

Jan 19, 2021

04:48PM EST Alkido Pharma Reports On Jan. 12, 2021 Co Did Not Obtain Approval From Stockholders That Held A Majoirty Of Ussued And Outstanding Shares Benzinga

Jan 11, 2021

10:12AM EST 5 Value Stocks To Watch In The Healthcare Sector Benzinga

08:32AM EST Silo Pharma Provides Details Of Patent License Agreement For Psilocybin, Cancer Applications Benzinga

08:30AM EST Silo Pharma Provides Details of Patent License Agreement for GlobeNewswire Inc

Jan 6, 2021

08:32AM EST Benzinga Pro's Top 5 Stocks To Watch For Wednesday, Jan. 6, 2021: SKLZ, AIHS, PECK, AIKI, TACO Benzinga

08:17AM EST AIkido Pharma Executes Licensing Agreement For Psilocybin For Cancer Applications RTTNews

08:08AM EST AIkido Pharma Announces Execution Of Patent License Agreement For 'technology that covers the use of psilocybin for cancer applications' Benzinga

08:02AM EST AIkido Pharma Inc. Executes Licensing Agreement for Psilocybin for Cancer PR Newswire

Dec 21, 2020

09:54AM EST A Look Into Healthcare Sector Value Stocks Benzinga

Dec 9, 2020

10:02AM EST AIkido Pharma Reports Publication Of Results From AI/Machine Learning Sponsored Research Program In Field Of Pancreatic Cancer Benzinga

10:01AM EST AIkido Pharma Announces Publication of Artificial Intelligence-Machine Learning PR Newswire

Nov 20, 2020

08:09AM EST AIkido Pharma : All Stockholder Proposals Approved Other Than Authority For Reverse Stock Spilt RTTNews

08:01AM EST AIkido Pharma Inc. Announces Results of 2020 Annual Stockholder Meeting PR Newswire

Nov 13, 2020

09:01AM EST Alkido Pharma Announces Publication Of Favorable Peer Reviewed Study Of Newly Licensed Antiviral Compounds Benzinga

09:01AM EST AIkido Pharma Inc. Announces Publication of Favorable Peer Reviewed Study of PR Newswire

Nov 3, 2020

07:38AM EST The Daily Biotech Pulse: Aurinia Pulls The Plug On Dry Eye Disease Study, Karyopharm's Positive Readout, Emergency Use Authorization For OraSure Benzinga

Oct 28, 2020

01:33PM EDT AIkido Pharma Provides Update On Next-Generation Chemotherapeutic Treatment DHA-dFdC Benzinga

01:30PM EDT AIkido Pharma Inc. Provides Update on Its Next-Generation Chemotherapeutic PR Newswire

Sep 29, 2020

04:10PM EDT AIkido Pharma 8-K Shows Co. Received Nasdaq Deficiency Note Related To Compliance With $1/Share Minimum Bid Price Requirement; Co. Has Til Mar. 23, 2021 To Regain Compliance Benzinga

Sep 18, 2020

10:01AM EDT Alkido Pharma Announces Update On Co's Use Of Artificial Intelligence Benzinga

10:01AM EDT AIkido Pharma Announces Update On Its Use Of Artificial Intelligence PR Newswire

Sep 11, 2020

10:00AM EDT AIkido Pharma Inc. Announces Participation at the H.C. Wainwright 22nd Annual PR Newswire

09:06AM EDT AIkido Pharma Highlights Peer-Reviewed Publication Of Results From Study Of Antiviral Compounds Licensed From University Of Maryland Benzinga

09:05AM EDT AIkido Announces Publication Of Positive Results From Study Of Antiviral Compounds Licensed From University Of Maryland RTTNews

09:00AM EDT Study of Antiviral Compounds Licensed from University of Maryland, Baltimore PR Newswire

Aug 18, 2020

09:06AM EDT AIkido Pharma Sponsors Survival Study Of University Of Kentucky Anticancer Drug G4-1 In Exchange For Exclusive Option To License Benzinga

09:03AM EDT AIkido Pharma Sponsors Survival Study of University of Kentucky Anticancer Drug PR Newswire

Aug 14, 2020

09:00AM EDT AIkido Pharma Inc. to Present at The LD 500 Virtual Conference PR Newswire

Aug 11, 2020

10:05AM EDT AIkido Pharma Extends Previously-Disclosed Exclusive Option Deal With University Of Maryland, Extended Til Dec. 2, 2020 Benzinga

10:02AM EDT AIkido Extends Option To License Patented Treatment For Coronavirus RTTNews

10:00AM EDT Option for Treatment for Coronavirus Extended PR Newswire

Aug 3, 2020

10:03AM EDT AIkido Pharma Regains Compliance With NASDAQ Listing Requirements RTTNews

10:01AM EDT AIkido Pharma Reports Regained Compliance With NASDAQ Benzinga

10:01AM EDT AIkido Pharma Inc. Regains Compliance with NASDAQ Listing Requirements PR Newswire

Share